TVGN

Tevogen Inc. - Common Stock (TVGN)

About Tevogen Inc. - Common Stock (TVGN)

Tevogen, Inc. is a clinical-stage specialty immunotherapy company, which engages in the provision of off-the-shelf therapies for the treatment of infectious diseases, cancers, and neurological disorders. It focuses on its product, ExacTcell, a technology that treats acute viral infections, long-term consequences of viral infections, and viral and non-viral induced cancers. The company was founded in April 2021 and is headquartered in Warren, NJ.

Details

Daily high
$6.56
Daily low
$6.46
Price at open
$6.56
52 Week High
$39.00
52 Week Low
$3.64
Market cap
43.0M
Dividend yield
-
Volume
2,839
Avg. volume
8,517
P/E ratio
-1.13

Tevogen Inc. - Common Stock News

Details

Daily high
$6.56
Daily low
$6.46
Price at open
$6.56
52 Week High
$39.00
52 Week Low
$3.64
Market cap
43.0M
Dividend yield
-
Volume
2,839
Avg. volume
8,517
P/E ratio
-1.13